Hong Kong Biotech Stock News

SEHK:467
SEHK:467Oil and Gas

Assessing United Energy Group’s Valuation After 2025 Earnings Drop And Final Dividend Cancellation

Why United Energy Group’s latest results matter for shareholders United Energy Group (SEHK:467) just released its full year 2025 earnings, reporting sales of HK$19,191.27 million, lower net income compared with the previous year, and no recommended final dividend following a payout in the prior year. See our latest analysis for United Energy Group. United Energy Group’s share price has been volatile around the HK$0.55 level, with a 30 day share price return of a 32.93% decline contrasting...
SEHK:6618
SEHK:6618Consumer Retailing

How JD Health’s CF PharmTech Alliance and Equity Awards Strategy Will Impact JD Health (SEHK:6618) Investors

On March 20, 2026, CF PharmTech, Inc. announced a cooperation under which JD Health International will be the exclusive online launch platform for several major new respiratory and rhinology products over the next three years, while also exploring internet-based chronic disease management models together. Alongside this, JD Health’s recent grant of 834,412 new share awards with strict clawback terms and its deeper role in digital drug commercialization highlight how the company is tying...
SEHK:1288
SEHK:1288Banks

Agricultural Bank of China (SEHK:1288) Is Up 5.6% After Boosting 2025 Dividend On Solid Earnings

Agricultural Bank of China Limited has released its 2025 full-year results, reporting CNY 569,594 million in net interest income, CNY 291,041 million in net income, and proposing a final dividend of RMB 1.300 per ten shares on about 349.98 billion ordinary shares. The board’s move to raise the cash payout while offering H-share investors a choice of RMB or HK$ dividends underlines a focus on shareholder returns and flexibility in cross-border capital distribution. We’ll now examine how the...
SEHK:2595
SEHK:2595Biotechs

3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 46.6%

Amidst ongoing geopolitical tensions and energy market volatility, Asian markets have displayed mixed performance, with investors navigating both regional challenges and opportunities. In this environment, identifying undervalued stocks can be a strategic approach for investors seeking potential value plays, especially when these stocks are trading at significant discounts relative to their intrinsic worth.
SEHK:2025
SEHK:2025Auto Components

A Look At Ruifeng Power Group’s Valuation As Earnings And Dividend Guidance Draw Interest

Earnings and dividend move put Ruifeng Power Group in focus Ruifeng Power Group (SEHK:2025) has drawn investor attention after reporting full year 2025 results together with a proposed increase in its final dividend, combining earnings information with a clearer signal on shareholder payouts. For the year ended 31 December 2025, Ruifeng Power Group reported sales of CN¥1,109.4 million and net income of CN¥23.27 million, with basic earnings per share from continuing operations of CN¥0.029. See...
SEHK:3800
SEHK:3800Semiconductor

GCL Technology Holdings (SEHK:3800) Valuation Check After 2025 Earnings Show Lower Sales And Narrowed Net Loss

What GCL Technology Holdings' Latest Earnings Mean For Investors GCL Technology Holdings (SEHK:3800) released full year 2025 results, reporting sales of CN¥14,424.93 million compared with CN¥15,097.56 million a year earlier, and a narrowed net loss of CN¥2,867.89 million. See our latest analysis for GCL Technology Holdings. The latest results arrived after a period where the share price has been under pressure, with a 30 day share price return of an 11.32% decline and a 90 day share price...
SEHK:981
SEHK:981Semiconductor

Assessing Semiconductor Manufacturing International’s Valuation After Recent Share Price Weakness

Assessing Semiconductor Manufacturing International after recent share price weakness Semiconductor Manufacturing International (SEHK:981) has come under pressure recently, with the share price showing a 3.5% decline over the past day and a 16.7% drop over the past month. For investors, this invites a fresh look at how the current valuation aligns with the company’s scale and earnings profile. See our latest analysis for Semiconductor Manufacturing International. At the current share price of...
SEHK:3931
SEHK:3931Auto Components

Assessing CALB Group (SEHK:3931) Valuation After Strong 2025 Earnings And Share Price Momentum

CALB Group (SEHK:3931) has just released its full year 2025 results, reporting sales of CN¥44,400.07 million and net income of CN¥1,475.63 million. These figures may influence how you assess the stock. See our latest analysis for CALB Group. The earnings release appears to sit alongside strong recent momentum, with a 30 day share price return of 29.11% and a 1 year total shareholder return of 86.44%. Meanwhile, the 3 year total shareholder return of 71.16% suggests earlier gains were more...
SEHK:1114
SEHK:1114Auto

Assessing Brilliance China Automotive (SEHK:1114) Valuation After Mixed 2025 Earnings Results

Why Brilliance China Automotive’s latest earnings matter for shareholders Brilliance China Automotive Holdings (SEHK:1114) has just released full year 2025 results, reporting CNY 1,181.92 million in sales and CNY 1,985.69 million in net income, with earnings per share lower than in the prior year. See our latest analysis for Brilliance China Automotive Holdings. Brilliance China Automotive’s share price has pulled back recently, with a 30 day share price return showing a decline of 23.65% and...
SEHK:1378
SEHK:1378Metals and Mining

Assessing China Hongqiao Group’s Valuation After Full Year Results And Proposed Final Dividend

What the latest earnings and dividend proposal mean for shareholders China Hongqiao Group (SEHK:1378) has put fresh numbers on the table, reporting its full year 2025 results alongside a proposed final ordinary dividend of HK$1.65 per share, which puts cash returns in focus. For 2025, the company reported sales of CN¥162,353.73 million, compared with CN¥156,168.72 million a year earlier, and net income of CN¥22,636.11 million, compared with CN¥22,372.33 million in the prior year. Basic and...
SEHK:1361
SEHK:1361Luxury

Why 361 Degrees (SEHK:1361) Is Up 14.8% After FY2025 Earnings Beat And Dividend Proposal

361 Degrees International has reported its full-year 2025 results, with sales rising to CNY 11,145.83 million and net income reaching CNY 1,308.88 million, alongside higher basic and diluted earnings per share of CNY 0.633. The board’s recommendation of a final dividend of HK$0.113 per share, subject to shareholder approval, underlines the company’s willingness to return cash to investors following this earnings performance. With revenue growth and a proposed final dividend on the table,...
SEHK:1093
SEHK:1093Pharmaceuticals

Is It Too Late To Consider CSPC Pharmaceutical Group (SEHK:1093) After Its 81% One-Year Rally?

If you are wondering whether CSPC Pharmaceutical Group at HK$9.71 is still reasonably priced after a strong run, the starting point is to understand how its current share price lines up with different measures of value. The stock has returned 19.0% over the past 7 days, 5.3% over the last month, 14.5% year to date and 80.6% over the past year, which naturally raises questions about how much potential or risk is now priced in. Recent coverage has focused on how investors are reassessing large...
SEHK:354
SEHK:354IT

Assessing Chinasoft International (SEHK:354) Valuation After Chairman’s HK$3.43m Share Purchase And Latest Earnings

The Chairman of Chinasoft International (SEHK:354) recently bought 1 million shares for about HK$3.43 million, shortly after the company released its 2025 results and recommended a final dividend, subject to shareholder approval. See our latest analysis for Chinasoft International. The latest insider buying comes after a tougher price stretch, with the share price at HK$3.47 and a 90 day share price return of a 32.88% decline, alongside a 1 year total shareholder return of a 30.43% decline...